Skip to main content

Highlights

  1. 1
    Cell reports · 2020
    PMID: 32783948DOIFirst author31 citations
  2. 2
    Science advances · 2022
    PMID: 35263130PMCID: PMC8906729DOIFirst author13 citations
  3. 3
    Reproduction (Cambridge, England) · 2022
    PMID: 36194429PMCID: PMC9782463DOIFirst author9 citations

Publications

18 publications

Funding

2 grants

Active

1 grant
  • Co-I
    Anti-Mullerian hormone for preserving ovarian function before administration of gonadotoxic therapies or after transplantation of cryopreserved tissue.
    Eunice Kennedy Shriver National Institute of Child Health and Human Development · 2023–2028
    R01HD112441-01
Completed grants (1)
  • Co-I
    Optimized protocols for ovarian tissue cryopreservation and novel modRNA-based approaches to improve transplantation outcomes for fertility preservation in chronically diseased girls
    Eunice Kennedy Shriver National Institute of Child Health and Human Development · 2021–2024
    R21HD103956-01A1

Clinical research

1 study

Active

1 study
  • PI
    Unfolding a correlation between sequential analysis results for FMR1 gene of the parental sequence to the embryos' utilizing PGD results
    Weill Medical College of Cornell University · OPEN TO ACCRUAL (as of 2023)

News mentions

  • Anti-Müllerian Hormone May Contribute to Infertility in Polycystic Ovary Syndrome
    March 9, 2022

    High levels of anti-Mullerian hormone (AMH) have traditionally been thought of as merely a passive byproduct of polycystic ovary syndrome (PCOS), but a new preclinical study by Weill Cornell Medicine researchers suggests that the hormone plays an active role in the disorder and may contribute to problems with ovulation and fertility.